expiredbuysec_filings

DNA 10-Q report for 2026-03-31

This play summarizes the available excerpt of Ginkgo Bioworks Holdings, Inc. (DNA) Form 10‑Q for the quarter ended March 31, 2026. The provided document is only the filing cover/header and does not contain financial statements, MD&A, guidance, risk updates, or material disclosures that would support a high-confidence trade. The recommended strategy noted in this expired play was: buy — thesis: Fundamental acceleration supports DNA — outcome: failed.

Confidence
20 / 100
Assets
1
Authors
1
Outcome
failed

Linked assets

DNA (Ginkgo Bioworks Holdings, Inc.) — filing confirms continued reporting status and NYSE listing; the excerpt offers no new operational or financial detail.

DNAGinkgo Bioworks Holdings, Inc.buyfailed

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States.

Confidence: 15 / 100Start: $10.32Latest: $9.46Return: -8.33%

Only confirms the company filed a 10-Q for the quarter ended 2026-03-31 and is listed as DNA on NYSE; no incremental fundamental catalyst is present in the provided excerpt, so any trade would be speculative/flow-driven rather than thesis-driven.

Source proof

Source proof: Strong source proof | 3 extracted claims | 1 directional asset | 1 supporting author | headline-like title review

The source excerpt is limited to the SEC cover page/header of the registrant's Form 10‑Q for the period ended 2026-03-31. It contains issuer identity, ticker/listing, and filing metadata only; no statements of results, liquidity, guidance, or material events were included in the excerpt.

GEV 10-Q report for 2026-06-30
GE Vernova Inc. · Jul 22, 2026, 2:27 AM EDT

The provided excerpt is only the Form 10‑Q cover page for GE Vernova Inc. (GEV) for quarter ended 2026‑06‑30, with no financial statements, MD&A, segment results, guidance, backlog, risks, or other performance details included. As-is, it contains almost no trade-relevant incremental information beyond confirming the filing/period and listing details.

View source
SNBR 10-Q report for 2026-04-04
Sleep Number Corp · May 12, 2026, 3:06 AM EDT

This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.

View source
SOUN 10-Q report for 2026-03-31
SOUNDHOUND AI, INC. · May 11, 2026, 5:28 PM EDT

The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.

View source
WEAT 10-Q report for 2026-03-31
Teucrium Commodity Trust · May 11, 2026, 5:19 PM EDT

The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).

View source
ACHR 10-Q report for 2026-03-31
Archer Aviation Inc. · May 11, 2026, 5:01 PM EDT

The provided text is only the cover/header portion of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.

View source
CLSK 10-Q report for 2026-03-31
CLEANSPARK, INC. · May 11, 2026, 4:58 PM EDT

This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.

View source
ASTS 10-Q report for 2026-03-31
AST SpaceMobile, Inc. · May 11, 2026, 4:40 PM EDT

This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.

View source
SMCI 10-Q report for 2026-03-31
Super Micro Computer, Inc. · May 11, 2026, 4:38 PM EDT

This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.

View source

Supporting authors

Prepared from the provided filing-header text. One author contributed to the summary bundle. No additional company disclosures or management commentary were available in the excerpt.

Unlock full thesis monitoring

If you need a tradeable thesis, request the full 10‑Q or the company’s complete SEC filing to review financial statements, MD&A, liquidity and risk-factor disclosures. Use the full filings to evaluate fundamentals, runway, and any catalysts before trading.

DNA 10-Q report for 2026-03-31 | AI Frontrunner